Key Takeaways
- Shares of Everpure climbed 10% Monday following a Susquehanna upgrade from Neutral to Positive
- The firm increased its price target to $120 from $85, suggesting approximately 33% potential upside
- Hyperscaler demand for 2Tb QLC-based high-capacity SSDs is accelerating after prolonged delays
- Morgan Stanley separately upgraded shares to Overweight with a $108 target price
- The company reports Q2 FY2027 results on August 26, with analysts expecting $0.58 EPS on $1.1B revenue
Shares of Everpure (P) surged 10% during Monday’s early session after Susquehanna elevated its rating from Neutral to Positive while simultaneously boosting its price target to $120 from $85.
The revised target represents potential upside of approximately 33% based on Friday’s closing price. Shares opened Monday’s trading session at $89.92.
According to Susquehanna analyst Mehdi Hosseini, recent industry channel checks indicate that demand for 2Tb QLC-based high-capacity SSDs is beginning to materialize after experiencing delays spanning nearly 12 months.
“When combined with Everpure’s extensive and well-diversified product lineup, we believe this development has resulted in a more balanced hyperscaler customer base,” Hosseini stated in Monday’s research note to investors.
According to Hosseini’s analysis, this strategic positioning enables the company to capitalize on heightened procurement activity for mass-capacity SSDs during the latter half of 2026, especially for key-value cache offloading use cases.
Margin Expansion Opportunity
Hosseini also highlighted enterprise customers as an additional catalyst for growth, pointing to infrastructure modernization cycles and storage requirements for on-premises AI inference workloads.
Revenue generated from hyperscaler clients typically delivers gross margins ranging from 75% to 85%. Everpure’s latest quarterly results, which reflected zero hyperscaler product revenue, showed GAAP gross margin of 68.7% and adjusted gross margin of 70.1%.
This suggests that any acceleration in hyperscaler sales volume could drive substantial margin improvement.
Morgan Stanley joined the bullish chorus Monday, elevating Everpure to Overweight from Equal Weight while increasing its price objective from $87 to $108.
The overall analyst sentiment leans positive. Among 21 analysts tracking the stock, 15 maintain Buy recommendations, five rate it a Hold, and one recommends Sell. The average price target stands at $98.30.
Upcoming Earnings Catalyst
Everpure is scheduled to announce Q2 FY2027 financial results following the closing bell on August 26. Consensus estimates call for adjusted earnings of $0.58 per share on revenue of $1.1B.
The company exceeded expectations in its previous quarter, delivering EPS of $0.47 compared to the $0.40 estimate, while revenue reached $1.05B versus the $997.88M consensus forecast. This represented year-over-year revenue growth of 35.2%.
One noteworthy development: company insiders have offloaded $25.8 million in shares during the past 90 days, including two director-level transactions executed in late June.
Institutional investors hold 83.42% of outstanding shares, with Goldman Sachs increasing its stake by more than 100% during Q1 by acquiring an additional 595,307 shares.
Everpure trades within a 52-week range spanning $54.37 to $100.59 and maintains a market capitalization of roughly $29.89 billion.
Get 3 Free Stock Ebooks
Discover top-performing stocks in AI, Crypto, and Technology with expert analysis.
- Top 10 AI Stocks - Leading AI companies
- Top 10 Crypto Stocks - Blockchain leaders
- Top 10 Tech Stocks - Tech giants
